Viatris, Inc. (VTRS)
17.05
+1.10
(+6.90%)
USD |
NASDAQ |
May 07, 09:44
Viatris Cash from Investing (Quarterly) : -211.20M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | 785.00M |
| Baxter International, Inc. | -133.00M |
| Zimmer Biomet Holdings, Inc. | -159.00M |
| Dentsply Sirona, Inc. | -53.00M |
| Theravance Biopharma, Inc. | 0.588M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 815.80M |
| Cash from Financing (Quarterly) | -236.40M |
| Free Cash Flow | 1.851B |
| Free Cash Flow Per Share (Quarterly) | 0.491 |
| Free Cash Flow to Equity (Quarterly) | 587.30M |
| Free Cash Flow to Firm (Quarterly) | 685.48M |
| Free Cash Flow Yield | 9.27% |